Decrease or loss of MHC-II expression in B cell lymphoma has been associated with genetic alterations, such as CIITA deficiency, and is associated with poor survival in human B cell lymphoma. This evidence concerns the gene CIITA and B-cell non-Hodgkin lymphoma.